Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial
Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.7.0 has been added to the record history, and the previous entry v3.6.6 has been removed. This updates the page’s version history to reflect the latest administrative change.SummaryDifference0.1%

- Check38 days agoChange DetectedAn additional revision entry v3.6.6 was added to the record history. The previous v3.6.5 entry was removed, reflecting an update to the page's version history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision label updated from v3.6.4 to v3.6.5, reflecting a new site build rather than changes to the trial record.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry, Revision: v3.6.4, has been added to the study record history, replacing the previous revision. This indicates a system or UI update to the page without changes to the study data.SummaryDifference0.1%

- Check96 days agoChange DetectedRecord history now lists Revision: v3.6.3, replacing the previous Revision: v3.6.2 in the version entries. This reflects an update to the history metadata on the page.SummaryDifference0.1%

- Check103 days agoChange DetectedA new page revision entry (v3.6.2) was added to the Record History, replacing the previous (v3.6.0). This update reflects a version change in the page rather than a change to study data or results.SummaryDifference0.1%

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.